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Abstract: 
Background & Aims: Barriers to dissemination and engagement with 
evidence pose a threat to implementing evidence-based medicine. 
Understanding, retention and recall can be enhanced by visual presentation 
of information. The aim of this exploratory research was to develop and 
evaluate the accessibility and acceptability of visual summaries for 
presenting evidence syntheses with multiple outcomes to professional and 
lay audiences.  
Methods: ‘Evidence flowers’ were developed as a visual method of 
presenting data from four case scenarios: two complex evidence 
syntheses, Cochrane reviews and clinical guidelines. Petals of evidence 
flowers were coloured according to the GRADE evidence rating system to 
display key findings and recommendations from the evidence summaries. 
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Application of evidence flowers was observed during stakeholder 
workshops. Evaluation and feedback was conducted via questionnaires and 
informal interviews.  
Results: Feedback from stakeholders on the evidence flowers collected 
from workshops, questionnaires and interviews was encouraging and 
helpful for refining the flowers. Comments were made on content and 
design of the flowers, as well as usability and potential for displaying 
different types of evidence.  
Conclusions: Evidence flowers are a novel and visually stimulating method 
for presenting research evidence from evidence syntheses with multiple 
exposures or outcomes, Cochrane reviews and clinical guidelines. To 
promote access and engagement with research evidence, evidence flowers 
may be used in conjunction with other evidence synthesis products, such 
as (lay) summaries, evidence inventories, rapid reviews and clinical 
guidelines. Additional research on potential adaptations and applications of 
the evidence flowers may further bridge the gap between research 
evidence and clinical practice. 
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Abstract 
Background & Aims: Barriers to dissemination and engagement with evidence pose a threat 
to implementing evidence-based medicine. Understanding, retention and recall can be 
enhanced by visual presentation of information. The aim of this exploratory research was to 
develop and evaluate the accessibility and acceptability of visual summaries for presenting 
evidence syntheses with multiple exposures or outcomes to professional and lay audiences. 
Methods: ‘Evidence flowers’ were developed as a visual method of presenting data from four 
case scenarios: two complex evidence syntheses with multiple outcomes, Cochrane reviews 
and clinical guidelines. Petals of evidence flowers were coloured according to the GRADE 
evidence rating system to display key findings and recommendations from the evidence 
summaries. Application of evidence flowers was observed during stakeholder workshops. 
Evaluation and feedback was conducted via questionnaires and informal interviews. 
Results: Feedback from stakehold rs on the evidence flowers collected from workshops, 
questionnaires and interviews was encouraging and helpful for refining the design of the 
flowers. Comments were made on the content and design of the flowers, as well as the 
usability and potential for displaying different types of evidence. 
Conclusions: Evidence flowers are a novel and visually stimulating method for presenting 
research evidence from evidence syntheses with multiple exposures or outcomes, Cochrane 
reviews and clinical guidelines. To promote access and engagement with research evidence, 
evidence flowers may be used in conjunction with other evidence synthesis products, such as 
(lay) summaries, evidence inventories, rapid reviews and clinical guidelines. Additional 
research on potential adaptations and applications of the evidence flowers may further bridge 
the gap between research evidence and clinical practice.  
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Introduction  
With rapidly increasing research output, barriers to accessibility and engagement with 
research are an emerging threat to evidence-based medicine.
1-3
 In 2010, over 75 trials and 11 
systematic reviews of trials were published daily,
4
 and publication rates have increased since. 
With a predicted 50% growth rate in health literature,
5
 distilling the information overload has 
become necessary for evidence-based medicine to thrive. Given that systematically 
synthesised evidence may be regarded as the Holy Grail of evidence-based medicine,
6
 
evidence based health information in the form of systematic reviews and clinical guidelines 
have the potential to improve processes of care and patient outcomes. Evidence-based 
syntheses form the basis for future research and offer healthcare service providers the 
information needed to implement effective, evidence-based services.  
Systematic reviews represent the highest level of research evidence
7
 and provide clinicians 
with research summaries to help them stay abreast of current evidence-based 
recommendations, thus informing b st practice. However, managing the continually growing 
number of systematic reviews and clinical guidelines is not feasible for most health 
professionals.
2
 In addition, technical language, large volumes of text, and difficulties 
identifying key review findings, deters engagement and implementation of research evidence 
into practice.
2
 Words used by doctors and health professionals to describe their information 
supply include “overwhelming, difficult, daunting, choked, despairing, saturation, exhausted, 
frustrated, dreadful, and unrealistic”;
8,9
 “time consuming, demanding and stressful”.
9,10
 It 
appears that for health professionals, the utility of evidence-based information is inversely 
proportional to the volume of work required to access it.
11
 
Research suggests that the ‘human bandwidth’ or capacity to take in, comprehend, and 
efficiently synthesize large amounts of new information can be greatly enhanced by visual 
presentation of information.
12-16
 Similarly, recall, retention and re-use of visual information is 
significantly greater than that of textual information.
12-17
 These concepts have proved to be 
increasingly useful for the communication of health information between health care 
providers and patients.
17
 However, visual presentation of evidence synthesis appears less 
explored for health professionals, stakeholders and policy makers. Considering these issues, it 
was proposed that the development of a succinct, visual format of presenting large bodies of 
synthesised evidence would facilitate accessibility, acceptability, engagement and usability of 
the research evidence to wider and more varied stakeholder groups.  
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The first evidence flowers were designed to visually present the findings from a large 
complex evidence synthesis of the effectiveness of interventions for treating the five common 
musculoskeletal pain conditions within the STarT MSK research programme at Keele 
University (see below). The aim was to find a way to present information contained in 
extensive summary tables in a format that was engaging, as well as easily and quickly 
understood by all the research programme’s stakeholders (health professionals, researchers, 
members of the general public and health providers). The specific objectives were to:  
i. develop pictorial graphics (evidence flowers) for presenting a succinct overview of 
evidence syntheses with multiple exposures (e.g. interventions) or outcomes that also 
indicated the strength of the evidence;  
ii. explore the usability, accessibility and acceptability of the evidence flowers to 
professional and lay audiences with differing needs, experiences, and preferences;   
iii. suggest other applications where evidence flowers might be used to summarise 
evidence syntheses; and  
iv. discuss future research to formally evaluate and test evidence flowers. 
Four cases, or scenarios, for which evidence flowers were generated to provide visual 
summaries of evidence, are described in this paper. The first two cases (research programmes 
consisting of large, complex evidence syntheses) describe the development of the evidence 
flowers, Cases 3 and 4 are suggestions for other areas where evidence flowers might be 
applied to aid knowledge transfer to mixed audiences. The development and application of 
methods used to collate, disseminate and translate the synthesised evidence-based 
information into knowledge are reported. 
 
Development of the evidence flowers 
Case study 1: Stratification and Targeted Treatment of Musculoskeletal conditions - 
STarT MSK
18
 
STarT MSK is a five-year programme of research that aims to improve patient outcomes by 
using a stratified approach to the management of common musculoskeletal pain 
presentations. Treatments that are matched to patient risk subgroups (or stratified) on the 
basis of prognostic information have been shown to improve patient outcomes and/or reduce 
health care costs in the primary care management of low back pain.
19,20
 To inform the 
development of treatment strategies matched to patient risk subgroups for a wider range of 
musculoskeletal pain presentations, an overview and critical appraisal of current best 
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evidence of the available treatment options used in primary care for common musculoskeletal 
conditions was conducted.
21
 These evidence summaries of treatment effects were then used 
by stakeholder and expert consensus groups to identify the most promising treatments for the 
different prognostic subgroups.  
Case study 2: Improving care for people with long term conditions – ENHANCE
22,23
 
The aim of the ENHANCE study was to develop and test the feasibility and acceptability of a 
complex intervention for tackling the under-recognition and suboptimal management of 
anxiety and/or depression and osteoarthritis (OA)-related joint pain in patients with long term 
conditions (LTCs) in primary care. Developing the enhanced consultation and the training for 
practice nurses for the ENHANCE study required synthesis of the evidence on effective 
methods for identification and management of anxiety, depression and OA-related joint pain 
in primary care. Guidelines, systematic reviews and other available evidence concerning the 
primary care management of the four LTCs (Asthma, Chronic Obstructive Pulmonary 
Disease (COPD), Cardiovascular Disease/Hypertension, and Type 2 Diabetes) were also 
reviewed. 
 
Methods  
Development of the evidence flowers was an iterative process that followed the principles of 
contextual design 
24
 and co-design 
25
. Evaluation and feedback techniques were used to 
observe the use of the evidence flowers and collect comments from the diverse groups 
involved in order to refine the design of the evidence flowers for presenting research 
evidence.  
The large, independent evidence syntheses conducted for STarTMSK and ENHANCE 
research programmes, comprised of systematic searches of bibliographic databases (including 
Cochrane database of systematic reviews, Database of abstracts of reviews of effects, Health 
Technology Assessment database, MEDLINE and EMBASE (using specific search filters to 
retrieve systematic reviews and clinical guidelines)), and evidence sources (Clinical 
Knowledge Summaries, Map of Medicine, TRIP Database, reference lists of included 
systematic reviews and guidelines, research stakeholders and experts in the field) for the most 
recent, high quality reviews, clinical guidelines and policy documents.  The evidence 
syntheses used pre-appraised evidence, such as clinical guidelines, policy documents, clinical 
evidence pathways and evidence summaries, wherever possible as the starting point due to 
Page 6 of 24Research Synthesis Methods
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
Evidence Flower Manuscript 
 
5 
 
the broad topic areas being addressed, similar to the 6s pyramid model described by 
26
. The 
methods and results of these syntheses will be published elsewhere.   
Information from evidence syntheses can be complex with multiple aspects to consider. Risk 
of bias and confounding, strength of recommendations, design of primary sources of data, 
magnitude of effect, level of precision, directedness, the dose response gradient of evidence, 
and consistency of results across sources of evidence, may all affect interpretation of the 
evidence. Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
takes all these points into consideration by downgrading evidence where these issues arise 
27,28
. GRADE criteria is often applied by systematic reviewers and guideline developers to 
indicate the strength of the body of evidence supporting summary statements or 
recommendations. Therefore, GRADE seemed a practical system on which to base the 
evidence flowers.  
The strength of evidence in both STarTMSK and ENHANCE syntheses was assessed using a 
modified GRADE approach. Given the varying study types and different levels of evidence 
being synthesised, GRADE levels of evidence were modified and applied consistently and in 
a standardised format across the available sources of evidence. For each treatment option (in 
STarTMSK) or condition (in ENHANCE), strength of evidence was classified as: 
• “Gap in evidence” – Where no published or unpublished evidence has been found   
• “Weak evidence” - based solely on expert opinion or consensus in guidelines only or 
in the absence of systematic review evidence 
• “Limited evidence” - in the presence of little evidence from systematic 
reviews/evidence-based guidelines AND when there were small, inconsistent, or non-
significant treatment effect sizes from primary studies (trials)  
• “Moderate evidence” – in the presence of little evidence from systematic 
reviews/evidence-based guidelines (as in 2) but showing a medium to large treatment 
effect in trials OR in the presence of strong evidence from high quality systematic 
reviews, but with small or inconsistent treatment effect sizes  
• “Strong evidence” - in the presence of strong evidence from high quality systematic 
reviews and evidence-based clinical guidelines AND medium or large effect sizes 
from trials.  
Use of a flower design enabled presentation of a number of different treatment options or 
different outcomes to be represented (depending on the type of evidence presented) as petals, 
with the colour of the petal representing the GRADE rating of the evidence supporting each 
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option. (Fig. 1). The results of evidence syntheses were summarised and evidence flowers 
produced. The synthesised evidence was subdivided such that each flower contained 
information relative to a specific health condition or area of interest (for example, see the 
summary of evidence for treatments of cervical radiculopathy in STarT MSK; and for case-
finding and assessment of osteoarthritis in multimorbidity for ENHANCE, Fig. 2). The petals 
represented the treatment or management options available and the colour indicated the 
GRADE rating of the evidence. The resulting evidence flowers formed a simple 
representation of the strength of current best evidence and a summary of the evidence 
syntheses (Fig. 2).  
The evidence flowers were used alongside traditional evidence summary tables, which were 
also available for consultation when more detailed information was required. Both the 
evidence flowers and the summary tables were presented to stakeholder groups (consisting of 
policy decision makers, commissioners, health service managers, clinicians, and patient 
representatives) in a series of workshops that aimed to facilitate dissemination of current best 
evidence and inform the development of the next stage in each research programme.  
For the STarT MSK programme, the stakeholder workshops focused on identifying effective 
treatment options (based on findings from the evidence syntheses), which would be most 
suitable for patient risk subgroups (i.e. patients at low, medium, or high risk of persistent, 
disabling pain). After the workshop, evidence flowers were revised according to consensus 
opinion, developing and adapting them to facilitate dissemination of evidence to the wide 
variety of end users. The revised flowers were then used in a series of expert consensus group 
meetings to determine matched treatment options for the STarT MSK stratified care trial.  
Accessibility, acceptability and engagement were explored via structured questionnaires 
(Appendix 1). The questionnaires were adapted from existing studies 
29,30
 and required 
responses from participants regarding experience of interpreting research evidence and 
evidence-based medicine skills, recognition and understanding of key messages presented in 
the evidence flowers, ease of access to and perceived value of the evidence flowers, and 
preferred summary formats. The questionnaires were reviewed (pilot-tested) by local 
researchers and clinicians.  
A similar process was observed during the initial phases of the ENHANCE trial, during 
which the evidence flowers were used to stimulate discussion at three separate stakeholder 
workshops, ultimately facilitating development of the new complex intervention. Evidence 
Page 8 of 24Research Synthesis Methods
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
Evidence Flower Manuscript 
 
7 
 
flowers were not formally assessed using questionnaires for the ENHANCE stakeholder 
workshops. However, feedback from stakeholders not only informed modifications to the 
evidence flowers, but was also used to refine the questionnaires used in the STarTMSK 
programme to gather more specific information during subsequent workshops. 
Results of evidence flowers evaluation and feedback 
In the ENHANCE study, feedback was positive (Table 1), including critical comments 
regarding concept, design, content and usability of the evidence flowers for presenting 
different types of evidence, or to different audiences. Informal feedback was gathered from 
stakeholders and experts who indicated interest in being contacted for further discussion a 
few weeks after the workshop.  
Discussions focused on collecting information about participants’ experiences of using the 
evidence flowers for accessing synthesised evidence, their own use of research evidence and 
views on potential use of evidence flowers in research, policy and clinical practice. The 
concise content presented through the evidence flowers was considered to be a strength.  
There were discussions about standardising the amount of text on all petals representing 
different treatment options. Regarding strength of evidence, the GRADE rating system was 
generally well accepted but there were conflicting comments about indicating the direction 
(i.e., positive or negative) of treatments effects on evidence flowers, and specification of 
efficacy versus effectiveness information on the petals. A wide range of potential applications 
and usefulness in research, clinical practice and patient education were highlighted in 
discussions, this needs to be explored and tested in future studies.   
To evaluate the flowers, participants were asked to complete questionnaires at the end of the 
STarT MSK stakeholder workshop. Twenty-one people (eleven clinicians, five academic 
researchers, three epidemiologists, and two health service/trial managers) responded to the 
questionnaire out of 22 eligible attendees. In total, 27 people attended the workshop, but five 
were researchers who were either involved with facilitating the workshop or directly involved 
in the evidence synthesis/development of evidence flowers and therefore not eligible). Out of 
21 responders, 18 found it easy to understand visual presentation of evidence in form of 
evidence flowers, while three out of 21 were not certain evidence flowers helped them to 
carry out set tasks for the stakeholder workshop. Nearly half, nine out of 21 thought changes 
could be made to evidence flowers to further enhance its usability. Details of responses to 
questionnaire items for the STarT MSK stakeholder group are presented in Table 1.  
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The development and concept of the evidence flowers in these two cases as visual 
representation of complex evidence syntheses was presented at scientific conferences. This 
provided national and international opportunities to stimulate further debate and inform 
dialogue with a wider audience around how to translate synthesised evidence into clinical 
practice and policy.
31-33
 
 
Potential Applications 
Case study 3: Cochrane reviews 
Whilst widely recognized as a gold standard of evidence-based health care resources, 
Cochrane reviews are not without accessibility problems for health care professionals.
29
 
Despite potential solutions, such as characteristics of studies and Summary of Findings 
tables, to facilitate the uptake of information from Cochrane reviews, statistical information 
and large volumes of text results remain difficult to read and interpret quickly potentially 
limiting their use for health professionals in clinical practice.  
Alternative methods of visually presenting the Cochrane evidence may improve accessibility. 
It was hypothesised that when used in conjunction with Summary of findings tables, evidence 
flowers may make evidence more accessible to a variety of audiences. For five Cochrane 
reviews containing summary of findings tables (purposively selected to represent a range of 
topic areas or specialties), evidence flowers were created.
34
 The petals of the evidence 
flowers represented evidence of the effectiveness of treatment for different outcome 
measures, and were coloured according to the GRADE evidence rating system given by the 
Cochrane review authors in the published Summary of Findings tables. The standardised 
narrative summary on the petal was kept brief and written in plain language (Fig. 3). Effect 
sizes were indicated with a three-star grading system classifying effect sizes 
as small (d = 0.2), medium (d = 0.5), or large (d ≥ 0.8) (Carson).  
Case study 4: Evidence-based clinical guidelines 
Despite their potential to improve health care outcomes, clinical guidelines have been 
plagued with wide variations in implementation in clinical practice across health care 
professions and disease spectrums.
35
 Major barriers to guideline implementation include large 
volumes of text to read, time required to access documents, unclear formats of the guidelines 
and lack of motivation.
1,10,35
 Given that their impact is reliant on successful implementation, 
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the question remains as to how clinicians stay abreast of core recommendations and remain 
motivated to implement these in their practice. The feasibility of expressing core guideline 
recommendations in form of evidence flowers for improving stakeholder accessibility and 
engagement was explored.  
Two National Institute for Health and Care Excellence (NICE) guidelines, Depression in 
Adults
36
 and Osteoarthritis,
37
 were selected and evidence flowers representing core 
recommendations of the guidelines were created using an iterative process. This involved 
extracting relevant information into summary tables (Appendix 2), highlighting multiple 
clinical outcomes considered in the guideline, and guideline recommendations for 
management. Information to be included in the evidence flowers was subsequently generated 
using data from the evidence summary tables. As with previous case studies, the strength of 
the research evidence supporting each recommendation was indicated by using different 
coloured petals in the evidence flowers according to the grading (based on GRADE) 
allocated by the guideline development group. The narrative summary of the information on 
the petal was kept brief and written in plain language (Fig 4).  
Two members of the NICE working groups, who had been involved with the development of 
these guidelines, gave informal feedback to ensure agreement of the evidence flowers with 
the evidence published in the guidelines. Accessibility and acceptability of the evidence 
flowers for use in this context were also considered.  
Feedback and discussions centred mostly on reconciliation between the grade of evidence and 
the guideline working group recommendations to offer or not to offer particular treatment. 
For instance, despite the low quality of evidence in support of the effectiveness of patient 
education and advice for the management of osteoarthritis (Fig. 4), the recommendation of 
the guidelines group (based on consensus, clinical expertise and ethics in practice) was to 
offer patient advice and education as a core recommendation. Here, visual presentation with 
evidence flower suggests that lack of research evidence may not always be interpreted as 
having limited value in practice. It highlights the evidence flower’s potential to offer 
accessible summaries of complex evidence-based health information provided in clinical 
guidelines. 
Discussion 
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In an era where the call for better standards of care through the use of evidence-based 
healthcare is unprecedented, and health care professionals are expected to keep up to date 
with an ever increasing amount of health care evidence, there is an urgent demand for 
evidence-based syntheses that are accessible to a wide variety of audiences. The four 
evidence flower case descriptions presented in this paper are examples of how simple visual 
summaries of synthesised evidence may be used to display complex information.  
In the review by Dawes and Sampson,
38
 information seeking is more likely to occur and be 
successful if access is convenient, information is reliable, of high quality, applicable and can 
be put into practice quickly. Engagement with research evidence must be preceded by 
accessibility to the evidence. The evidence flowers were found in these cases to be a suitable 
method for presenting the results of evidence syntheses to various stakeholders with varying 
levels of research experience as well as in forums with conference audiences.  
Engagement and accessibility barriers related to the speed of use, recall and retention of 
information contained in systematic review and clinical guidelines were considered, at least 
partly, overcome with the use of evidence flowers. For instance, during the workshops, the 
stakeholders seemed to quickly perceive the overall effect and direction of evidence 
supporting each treatment and were able to refer to and engage with more detailed 
information in the supporting evidence tables and reports. Much of the synthesised evidence 
presented contained no meta-analysis and it was not possible to extract statistical summary 
estimates of treatment effects to include such information in the evidence flowers. Given the 
main aim of the flowers, which was to offer an overview of the evidence that is accessible to 
lay members of the public and healthcare professionals, the absence of quantitative data in 
the flowers was not considered a key issue. When discussing the evidence as presented in the 
flowers, our groups could access more detailed evidence tables that included summary 
estimates where available. Further testing with end-users should formally assess whether 
conclusions drawn from the evidence flowers alone is similar to conclusions when using 
evidence tables, and provides a correct and unbiased interpretation of the evidence. Evidence 
flowers were perceived by most participants in the stakeholder workshops to have helped in 
stimulating discussions around the body of evidence. Visual presentation of information, such 
as the evidence flower, may be useful as discussion starters in clinical practice or research 
settings, and health implementation science forums.  
Criticisms about the appearance of evidence flowers related to size and colour palette. 
Discussants weighed the pros and cons of varying the size of petals in relation to the strength 
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of evidence.  Further research and development will explore the impact of varying the size of 
the impact of varying the size of the petals in proportion to strength of evidence or the 
magnitude of effects. Based on the cases presented in this paper, 5-6 petals appear to be the 
optimal number of petals feasible for printed versions of the evidence flowers. Pragmatically, 
future adaptations of evidence flowers may need to be more suitable for online /web 
applications as this would also allow for adequate adjustment for size and shape of petals.  
Research has shown that colours have effect on attention, memory and recall.
39
 The current 
colour scheme was arbitrarily chosen to indicate contrast between each of the levels of 
evidence.  Feedback has included issues such as “colours are too feminine”, and the intuitive 
association of lighter colours with low quality evidence versus darker colours with high 
quality evidence by users. In order to enhance accessibility and acceptability, future 
development and application of the evidence flowers will benefit from a careful consideration 
of the colour palette used to represent the different grades of evidence and the effect this has 
on their interpretation and impact in different contexts and audiences.  
The initial design for the evidence flowers was manually created using standard software 
(MS Office) which is not optimal for efficiently generating the flowers in terms of fitting 
content, and increasing number or size of petals. Furthermore, given that evidence-based 
health information needs to be updated regularly, consideration needs to be given to ensuring 
the evidence flowers can be generated using an electronic (online) format which will allow 
easy formatting and updating of the evidence flowers, and offer links to more detailed 
evidence behind each recommendation if required.   
Evidence flowers were initially developed within the context of two specific research 
programmes when the need emerged to present a large, complex body of evidence in a way 
that was suitable for a wide range of stakeholders. Therefore, evaluation of its potential to 
enhance accessibility, acceptability and engagement with synthesised research evidence is 
limited at present to the four case studies reported here. Weaknesses of this exploratory 
research relates mainly to the small number of participants taking part in workshops and 
completing questionnaires, as well as the lack of rigorous evaluation methods. However, 
early results for the use of evidence flowers are promising, and the concept has been 
generally well received by professionals and lay health audiences in national and 
international forums where it has been presented. Well-designed research studies evaluating 
the application of visual presentation of synthesised evidence is an important next step. 
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The use of visual information has helped to advance other areas of learning and 
communication such as marketing, engineering and patient health information systems.
13,17
 
Our perception that engagement with research evidence may be enhanced by the use of 
evidence flowers is supported by previous research showing that a high proportion of people 
are visual learners.
12,15
 Many people make sense of a visual scene almost a million times 
faster than text, recognise as well as retain more visual details than text, and it is thought that 
this may consequently increase the likelihood of recollecting and re-using information .
12,15
 
However, the long or short term recollection, interpretation and re-use of evidence presented 
in the evidence flowers has yet to be formally tested.   
The evidence flowers have not yet been explored for presenting evidence summaries to 
patients and the general public outside the research or conference environment. However, 
synthesised evidence is increasingly presented directly to the general public in order to 
increase health literacy and enable them to make shared, evidence-informed health decisions. 
Further work on the evidence flowers with patients and the public may provide insight into if 
and how evidence flowers can be used to present the information needed to facilitate shared 
decision making with their health care providers. Research in the future will also need to 
include an examination of the reliability and validity of evidence flowers for presenting and 
interpreting evidence, as well as a more rigorous evaluation of the impact of evidence flowers 
when used to enhance accessibility uptake of evidence in clinical practice.  
Conclusions 
Evidence flowers are a novel and visually stimulating method for presenting research 
evidence. To promote access to and engagement with research evidence, evidence flowers 
may be used in conjunction with complex evidence syntheses with multiple exposures or 
outcomes, Cochrane reviews and clinical guidelines. Further research on potential adaptations 
and applications to a variety of audiences is planned in order to more thoroughly examine the 
potential usefulness and impact of using the flowers.  
Highlights 
What is already known:  
• Technical language, large volumes of text, and difficulties identifying key review 
findings, deters engagement and implementation of research evidence into practice. 
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• With rapidly increasing research output, distilling the information overload has 
become necessary for evidence-based medicine to thrive. 
What is new: 
• To promote access and engagement with research evidence, Evidence flowers has 
been developed as a visual method of presenting research evidence. 
• Evidence flowers has been used to present research evidence from complex evidence 
syntheses with multiple outcomes, Cochrane reviews and clinical guidelines. 
Potential impact for RSM readers: 
• The use of evidence flower design with petals displaying health information and 
colours representing the strength of evidence enhances accessibility to succinct 
research evidence that is also visually appealing for lay and professional audience. 
• Future research on potential adaptations and applications of the evidence flowers may 
further bridge the gap between research evidence and clinical practice. 
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Table 1. Response to questionnaire & unedited comments from STarT MSK & ENHANCE Stakeholder 
Workshops 
 
Questions Response 
Responders 21 responders: clinicians (11), researchers (5), Epidemiologists (3), health 
service/trial managers (2) 
‘Evidence flowers’ easy to understand? 
1= easy; 2=neutral; 3=Difficult 
18 = easy; 2=neutral; 1=Difficult 
‘Evidence flowers’ help to match the 
treatments? 1= Yes; 2= No; 3= Unsure 
17= Yes; 2= No; 3= Unsure 
Any changes to the appearance of the 
flowers? 1= Yes; 2= No; 3= Unsure 
9= Yes; 11= No; 1= Unsure 
Comments if Yes • incorporate visual representation of efficacy 
• alter size of petals not just the colour to show evidence level/quality 
• colour coding hard to follow 
• more summaries of colours in quality and colours for amount of evidence  
• make size to show how effective +the colour to represent evidence  
• maybe find a way of distinguishing positive and negative evidence more clearly 
make all the petals identical 
Changes to the grading system used? 3= Yes; 16= No; 2= Unsure 
Comments if Yes • Difference between evidence…+efficacy 
• Differentiate strength of evidence from quality of evidence 
size of petals relate to amount of evidence + colour quality 
Changes to the content of the flowers? 3= Yes; 16= No; 2= Unsure 
Comments if Yes • some options need more detail 
• useful to be backed up by more detail/explanation of terms on separate sheet as 
was the case today 
• get rid of extra content 
Better format rather than coloured petals? 
Audience for Evidence flowers? 
1=Patients; 2=  Service providers; 3= 
Commissioners; 4= Healthcare 
managers; 5= Non-academic clinicians; 
6= Academic clinicians; 7= 
Researchers/Academics 
15-patients, 17-service providers, 16-commissioners, 18-health care managers, 
19-non-academic clinicians, 18-academic clinicians, 15-researchers/academics 
Further comments 
Comments on Useability & 
Acceptability of Evidence 
• Useful for presenting evidence of efficacy 
• Rapid summaries of evidence  
• Situations like option grids comparing interventions for patient decision aids. 
An aide …for clinician deciding on treatment pathways  
• Comparative summaries of evidence; summary of evidence  
• Education, training, patient care  
• Individual treatment decision choices/ Education /teaching resources 
• NICE guidelines would benefit from this type of approach  
• Focus groups for research/ clinical environments to summarise evidence 
• When deciding which treatment options to use  
• Helpful as a visual summary but also needs the evidence tables  
• as part of a presentation to /or a debate with other groups…. much easier to 
digest tan tables…. probably needs cross referencing to actual evidence- 
hyperlinks?  
• GP training on best practice…physio training on best practice…patient 
education on treatment options  
• Where variety of treatment options available, especially where limited 
evidence for benefit on some options 
• For commissioning protocols  
• Presenting evidence to patients/ presenting research to GPs /HCPs  
• Good way to summarise evidence-ideally interactive so could click on to get 
more detail  
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• Useful summary 
• We have been thinking of a way to our disseminate service audits, this could 
probably help 
• Unclear who the flowers are aimed at – layperson, clinician etc.? 
 
Comments on Accessibility • Good visual representation – able to take evidence in at a glance 
• Use as part of presentation to Clinicians /or a debate with other groups….much 
easier to digest reports and tables 
Comments on Engagement with 
evidence 
• Could be used in comparative summaries of evidence in training, patient care 
• good way to summarise evidence-ideally interactive so could click on to get 
more detail 
• “May be useful for commissioners” ; useful to be backed up by more detail 
/explanation of terms 
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Fig 1: Generic evidence flower, GRADE and interpretation of scheme  
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Fig 2: Evidence flower example: STarT MSK summary of evidence for cervical radiculopathy; &  
ENHANCE summary of evidence for case-finding and assessment of osteoarthritis in multimorbidity  
 
 
995x705mm (96 x 96 DPI)  
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Figure 3. Evidence flowers presenting Summary of Findings tables in two Cochrane reviews -Taylor et al. 
2014; Anderson et al. 2015.  
(23rd Cochrane Colloquium Jordan et al 2015)  
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Figure 4: Evidence flowers illustrating Guideline recommendations for the management of Osteoarthritis and 
Depression  
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